Dr. Giorgio A. Roccaro, MD

Dr. Roccaro practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Roccaro's NPI, 1205121985, was assigned on June 10, 2011. Dr. Roccaro graduated from State University of New York Downstate Medical Center in 2011. Dr. Roccaro holds Georgia license 79712.

Dr. Roccaro's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Roccaro's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Roccaro is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Roccaro to 3 more hospitals, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roccaro practices, 7 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Roccaro's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dmand AI has Dr. Roccaro's licenses on file in 2 states: Georgia and Massachusetts.

CMS data shows 206 Medicare services from Dr. Roccaro across 6 procedure codes in 2024, for 173 Medicare patients. Medicare paid $16,721 for them.

CMS counts 173 Medicare patients who saw Dr. Roccaro in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roccaro's median patient age at 65, with 49% women.

In 2024, Dr. Roccaro wrote 1,904 Medicare Part D claims for 281 patients. 88% of them were for generic drugs. CMS names the drug for 1,589 of them, across 28 drugs with 11 or more claims each, at $465,296 in total drug cost. In 2023, CMS named 1,316 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Roccaro for performance year 2024, reported through an alternative payment model (APM). Dr. Roccaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Roccaro as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 25 general payments to Dr. Roccaro from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. FUJIFILM Healthcare Americas Corporation paid the most, $7,436.

Dr. Roccaro graduated from State University of New York Downstate Medical Center in 2011.